Evaluation of a low-invasive strategy for prostate cancer screening with prostate-specific antigen

By Barette M.   Renard F.   Peltier A.   van Velthoven R.   Huet F.   Grivegnee A.R.   Autier P.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 712-716

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

By Krumholtz J.S.   Carvalhal G.F.   Ramos C.G.   Smith D.S.   Thorson P.   Yan Y.   Humphrey P.A.   Roehl K.A.   Catalona W.J.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 469-473

Elsevier

Access to resources Recommend Favorite

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria 1

By Bartsch G.   Horninger W.   Klocker H.   Reissigl A.   Oberaigner W.   Schonitzer D.   Severi G.   Robertson C.   Boyle P.   the Tyrol Prostate Cancer Screening Group  

Urology, Vol. 58, Iss. 3, 2001-09 ,pp. : 417-424

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen-based early detection of prostate cancer-validation of screening without rectal examination

By Schroder F.H.   Roobol-Bouts M.   Vis A.N.   van der Kwast T.   Kranse R.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 83-90

Elsevier

Access to resources Recommend Favorite